StockDrifts LogoStockDrifts

Nanochemtech 091970

Company
나노캠텍Nanochemtech
Insiders
2
Buys
4
Total Value
₩307M ($213K)
Avg Return
+28.27%
Last Filing
2026-06-17

Nanochemtech (091970) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩307M ($213K) in reported transaction value. The earliest filing StockDrifts holds for Nanochemtech is dated 2024-07-29; the most recent is 2026-06-17. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +28.27%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-17BUYMarket Buy
김태수
Kim Tae-soo
moving3.1K₩3,225+10.7%₩10M ($7K)
2026-06-12SELL전환등
신해용
Shin Hae-yong
Internal director-17.1K₩3,025-18.0%₩52M ($36K)
2026-05-05SELL주식병합
트리니티에쿼티
Trinity Equity
--6.9M₩3,785-12.7%₩25.9B ($18.0M)
2026-05-05SELL행사가액조정
트리니티에쿼티
Trinity Equity
--3.8M₩3,785-12.7%₩14.5B ($10.1M)
2026-05-05SELL주식병합
이상규
Lee Sang-gyu
Chairman-1.9M₩3,785-12.7%₩7.2B ($5.0M)
2026-05-05SELL주식병합
디비인베스트먼트
DB Investment
--411.7K₩3,785-12.7%₩1.6B ($1.1M)
2026-05-05SELL행사가액조정
신해용
Shin Hae-yong
Internal director-68.4K₩3,785-12.7%₩259M ($180K)
2026-05-05SELL주식병합
신해용
Shin Hae-yong
Internal director-91.1K₩3,785-12.7%₩345M ($240K)
2026-05-05SELL주식병합
소병적
petit pathological
Managing Director-41.0K₩3,785-12.7%₩155M ($108K)
2026-03-05BUYMarket Buy
디비인베스트먼트
DB Investment
-31.2K₩480+50.0%₩15M ($10K)
2026-03-03BUYMarket Buy
디비인베스트먼트
DB Investment
-53.8K₩555+29.7%₩30M ($21K)
2026-02-27BUYMarket Buy
디비인베스트먼트
DB Investment
-429.6K₩587+22.7%₩252M ($175K)
2025-11-04SELL전환등
소병적
petit pathological
Managing Director-51.3K₩847+15.0%₩43M ($30K)
2025-11-04BUY전환사채의권리행사
소병적
petit pathological
Managing Director51.3K₩847-15.0%₩43M ($30K)
2024-07-29BUYCB인수
오희갑
Oh Hee-gap
moving51.3K₩571+26.1%₩29M ($20K)
2024-07-29BUYCB인수
신해용
Shin Hae-yong
Internal director85.5K₩571+26.1%₩49M ($34K)
2024-07-29BUYCB인수
소병적
petit pathological
Managing Director51.3K₩571+26.1%₩29M ($20K)
2024-07-29BUYCB인수
트리니티에쿼티
Trinity Equity
-4.8M₩571+26.1%₩2.7B ($1.9M)

Frequently asked questions

Who has been buying Nanochemtech stock?
2 distinct insiders have filed 4 disclosed insider purchases in Nanochemtech (091970), most recently on 2026-06-17. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Nanochemtech have?
Nanochemtech has 4 buy-side and 0 sell-side disclosures on record, covering ₩307M ($213K) in total reported value, spanning 2024-07-29 to 2026-06-17.
Where does StockDrifts get Nanochemtech insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Nanochemtech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.